Back to search
Locally Advanced or Metastatic Solid Tumors With PIK3CA-mutated
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Locally Advanced or Metastatic Solid Tumors With PIK3CA-mutated trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Locally Advanced or Metastatic Solid Tumors With PIK3CA-mutated trials you may qualify forAn international, multicenter, open-label, Phase 1/2 clinical study to evaluate the safety, tolerability, pharmacokinetic characteristics, and efficacy of GenSc…
HS-10352 is a highly potent and selective small molecule inhibitor of phosphoinositide 3-kinase (p110α). In preclinical studies, it demonstrated strong activity…